[go: up one dir, main page]

Varnavski et al., 2002 - Google Patents

Preexisting immunity to adenovirus in rhesus monkeys fails to prevent vector-induced toxicity

Varnavski et al., 2002

View PDF @Full View
Document ID
1183859838540256416
Author
Varnavski A
Zhang Y
Schnell M
Tazelaar J
Louboutin J
Yu Q
Bagg A
Gao G
Wilson J
Publication year
Publication venue
Journal of virology

External Links

Snippet

In an earlier study we evaluated innate immune responses to a first-generation adenoviral vector infused into the portal vein of rhesus monkeys who had never been exposed to adenovirus previously. In these animals, the systemic administration of E1/E3-deleted …
Continue reading at journals.asm.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
    • C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Similar Documents

Publication Publication Date Title
Varnavski et al. Preexisting immunity to adenovirus in rhesus monkeys fails to prevent vector-induced toxicity
Schnell et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors
Jooss et al. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
Brunetti-Pierri et al. Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates
Xiao et al. Adeno-associated virus as a vector for liver-directed gene therapy
Lieber et al. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors
Schiedner et al. Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors
Havenga et al. Improved adenovirus vectors for infection of cardiovascular tissues
Jooss et al. Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
Muruve et al. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo
Zhu et al. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and-independent pathways
Shayakhmetov et al. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity
Amalfitano et al. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted
Zaiss et al. The influence of innate and pre‐existing immunity on adenovirus therapy
Reddy et al. Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector
Tao et al. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver
Christ et al. Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response
Cichon et al. Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits
Sung et al. TNFα and IFNγ induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression
Parks et al. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors
Zhang et al. Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen-presenting cells
Chirmule et al. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs
Van Linthout et al. Persistent hepatic expression of human apo AI after transfer with a helper-virus independent adenoviral vector
Andrews et al. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII
Aurisicchio et al. Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis